RUA Life Sciences (LON:RUA) Issues Earnings Results

RUA Life Sciences (LON:RUA) announced its quarterly earnings results on Tuesday. The company reported GBX (0.33) earnings per share (EPS) for the quarter, Digital Look Earnings reports. RUA Life Sciences had a negative net margin of 3.26% and a negative return on equity of 2.03%. The company had revenue of GBX 275 million during the quarter.

RUA Life Sciences Price Performance

Shares of LON RUA opened at GBX 19.50 on Tuesday. The company has a debt-to-equity ratio of 18.95, a current ratio of 4.64 and a quick ratio of 7.32. RUA Life Sciences has a 1-year low of GBX 10.42 and a 1-year high of GBX 26.80. The company has a market capitalization of £12.10 million, a price-to-earnings ratio of -2.61 and a beta of 0.96. The business has a 50-day moving average of GBX 19.90 and a 200-day moving average of GBX 15.84.

About RUA Life Sciences

The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.